Unilateral Cortical Fluid-Attenuated Inversion Recovery–Hyperintense Lesions in Anti-Myelin Oligodendrocyte Glycoprotein–Associated Encephalitis With Seizures (FLAMES): An Under-recognized Entity - 20/08/20
Doi : 10.1016/j.pediatrneurol.2020.05.003
Adrian Budhram, MD 
Department of Neurology, Mayo Clinic, Rochester, Minnesota
Division of Neurology, Department of Clinical Neurological Sciences, University Hospital, London, Ontario, Canada
Ario Mirian, MD
Division of Neurology, Department of Clinical Neurological Sciences, University Hospital, London, Ontario, Canada
Eoin P. Flanagan, MBBCh
Department of Neurology, Mayo Clinic, Rochester, Minnesota
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota
Le texte complet de cet article est disponible en PDF.
| Financial support: There are no financial disclosures concerning the materials or methods used in this study or the findings specified in this article. |
|
| Conflicts of interest: Dr. Budhram and Dr. Mirian have no disclosures to report. Dr. Flanagan is a site principal investigator in a randomized placebo-controlled clinical trial of inebilizumab (A CD19 inhibitor) in neuromyelitis optica spectrum disorders funded by MedImmune/Viela Bio. He receives no personal compensation and just receives reimbursement for the research activities related to the trial. |
© 2020
Elsevier Inc. Tous droits réservés.
Vol 110
P. 99-100 - septembre 2020 Retour au numéro
Article précédent
- CAD Deficiency—Another Treatable Early Infantile Epileptic Encephalopathy
- Mahesh Kamate, Supriya Patil
- Prophylactic Antiepileptic Treatment in Tuberous Sclerosis
- Prerna Choudhury, Robert Spaull, Sam Amin, Andrew A. Mallick, Jayesh S. Patel, Finbar O’Callaghan, Andrew L. Lux
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?